DeMichele A, Cristofanilli M, Brufsky A, Liu X, et al. Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2- metastatic breast cancer in US real-world clinical practice. Breast Cancer Res 2021;23:37.
PMID: 33761995